UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways

The Journal of pharmacology and experimental therapeutics, 2003-09, Vol.306 (3), p.954

2003

Volltextzugriff (PDF)

Cell infiltration into a 3D electrospun fiber and hydrogel hybrid scaffold implanted in the brain

Biomatter (Austin, TX), 2015, Vol.5 (1), p.e1005527-e1005527

2015

Volltextzugriff (PDF)

Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways

The Journal of pharmacology and experimental therapeutics, 1995-11, Vol.275 (2), p.899

1995

Volltextzugriff (PDF)

Dopamine D3 (Auto)receptors Inhibit Dopamine Release in the Frontal Cortex of Freely Moving Rats In Vivo

Journal of neurochemistry, 1996-05, Vol.66 (5), p.2209-2212

1996

Volltextzugriff (PDF)

Generalization of serotonin (5-HT) 1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPAT

Neuropharmacology, 2001-06, Vol.40 (7), p.899-910

2001

Volltextzugriff (PDF)

Biomaterial design considerations for repairing the injured spinal cord

Critical reviews in biomedical engineering, 2011, Vol.39 (2), p.125-180

2011

Volltextzugriff (PDF)

Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297

European journal of pharmacology, 1994-11, Vol.265 (3), p.175-177

1994

Volltextzugriff (PDF)

Blockade of transmission at NMDA receptors facilitates the electrical and synthetic activity of ascending serotoninergic neurones

Brain research, 1994-09, Vol.656 (2), p.427-431

1994

Volltextzugriff (PDF)

Design and Development of a Cardiopulmonary Resuscitation Mattress

Journal of intensive care medicine, 2009-05, Vol.24 (3), p.195-199

2009

Volltextzugriff (PDF)

S 14297, a novel selective ligand at cloned human dopamine D3 receptors, blocks 7-OH-DPAT-induced hypothermia in rats

European journal of pharmacology, 1994-08, Vol.260 (2-3), p.R3-R5

1994

Volltextzugriff (PDF)

Effect of intraarterial verapamil on the diameter of vasospastic intracranial arteries in patients with cerebral vasospasm

Neurosurgical focus, 2006-09, Vol.21 (3), p.E15-5

2006

Volltextzugriff (PDF)

WAY 100,135 and (-)-tertatolol act as antagonists at both 5-HT1A autoreceptors and postsynaptic 5-HT1A receptors in vivo

European journal of pharmacology, 1993-08, Vol.240 (2-3), p.307-310

1993

Volltextzugriff (PDF)

P16 UV mutations in human skin epithelial tumors

Oncogene, 1999-09, Vol.18 (39), p.5477-5481

1999

Volltextzugriff (PDF)

The "g" factor in child psychology

Revue de neuropsychiatrie infantile et d'hygiene mentale de l'enfance, 1961-09, Vol.9, p.449

1961

Volltextzugriff (PDF)

Differential motility of p190bcr-abl- and p210bcr-abl-expressing cells: respective roles of Vav and Bcr-Abl GEFs

Oncogene, 2008-04, Vol.27 (19), p.2673-2685

2008

Volltextzugriff (PDF)

5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat

The Journal of pharmacology and experimental therapeutics, 1993-01, Vol.264 (1), p.95

1993

Volltextzugriff (PDF)

A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194

The Journal of pharmacology and experimental therapeutics, 1998-10, Vol.287 (1), p.187

1998

Volltextzugriff (PDF)

S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride

The Journal of pharmacology and experimental therapeutics, 1998-10, Vol.287 (1), p.167

1998

Volltextzugriff (PDF)

Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra

Brain research, 2001-11, Vol.920 (1-2), p.41-54

2001

Volltextzugriff (PDF)

Intracerebral dopaminergic transplants are not activated by electrical footshock stress activating in situ mesocorticolimbic neurons

Neuroscience letters, 1988-07, Vol.90 (1), p.83-88

1988

Volltextzugriff (PDF)

Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats

Journal of neurochemistry, 1997-12, Vol.69 (6), p.2616-2619

1997

Volltextzugriff (PDF)

Pseudo T-cell lymphoma with clonal expansion related to hypersensitivity to amoxicillin

Haematologica (Roma), 2005-01, Vol.90 (1), p.ECR03

2005

Volltextzugriff (PDF)

Spontaneous and graft-induced behavioral recovery after 6-hydroxydopamine lesion of the nucleus accumbens in the rat

Brain research, 1987-03, Vol.407 (2), p.376-380

1987

Volltextzugriff (PDF)

S 14671 : a novel naphthylpiperazine 5-HT1A agonist of high efficacy and exceptional in vivo potency

European journal of pharmacology, 1991-10, Vol.203 (2), p.319-322

1991

Volltextzugriff (PDF)

1 – 25 von 108

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(106)
magazinearticle
(2)

Sprache

Englisch
(72)
Französisch
(36)

Erscheinungsjahr

n.n

Thema

Humans
(70)
Male
(69)
Animals
(52)
Rats
(46)
Rats, Wistar
(33)
Female
(26)
Adult
(20)
Middle Aged
(18)
Biological And Medical Sciences
(17)
Dopamine - Metabolism
(16)
Piperazines - Pharmacology
(14)
Dopamine Antagonists - Pharmacology
(12)
Serotonin Receptor Agonists - Pharmacology
(12)
Medical Sciences
(11)
Mice
(11)
Receptors, Dopamine D3
(11)
Receptors, Serotonin - Drug Effects
(11)
Serotonin - Metabolism
(11)
Hiv
(9)
Hiv Infections - Drug Therapy
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways

Cell infiltration into a 3D electrospun fiber and hydrogel hybrid scaffold implanted in the brain

Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways

Dopamine D3 (Auto)receptors Inhibit Dopamine Release in the Frontal Cortex of Freely Moving Rats In Vivo

Generalization of serotonin (5-HT) 1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPAT

Biomaterial design considerations for repairing the injured spinal cord

Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297

Blockade of transmission at NMDA receptors facilitates the electrical and synthetic activity of ascending serotoninergic neurones

Design and Development of a Cardiopulmonary Resuscitation Mattress

S 14297, a novel selective ligand at cloned human dopamine D3 receptors, blocks 7-OH-DPAT-induced hypothermia in rats

Effect of intraarterial verapamil on the diameter of vasospastic intracranial arteries in patients with cerebral vasospasm

WAY 100,135 and (-)-tertatolol act as antagonists at both 5-HT1A autoreceptors and postsynaptic 5-HT1A receptors in vivo

P16 UV mutations in human skin epithelial tumors

The "g" factor in child psychology

Differential motility of p190bcr-abl- and p210bcr-abl-expressing cells: respective roles of Vav and Bcr-Abl GEFs

5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat

A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194

Similar post-lesion receptor readjustments following the unilateral 6-hydroxydopamine lesion of the dopaminergic mesotelencephalic system in neonatal and adult rats

S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride

Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra

Intracerebral dopaminergic transplants are not activated by electrical footshock stress activating in situ mesocorticolimbic neurons

Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats

Pseudo T-cell lymphoma with clonal expansion related to hypersensitivity to amoxicillin

Spontaneous and graft-induced behavioral recovery after 6-hydroxydopamine lesion of the nucleus accumbens in the rat

S 14671 : a novel naphthylpiperazine 5-HT1A agonist of high efficacy and exceptional in vivo potency

Aktive Filter

Suchergebnisse filtern